OppenheimerFunds’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-125,042
Closed -$4.52M 1909
2017
Q1
$4.52M Sell
125,042
-380,798
-75% -$13.8M 0.01% 849
2016
Q4
$25.3M Buy
505,840
+111,990
+28% +$5.61M 0.03% 502
2016
Q3
$20.7M Buy
393,850
+2,210
+0.6% +$116K 0.03% 556
2016
Q2
$16.2M Buy
+391,640
New +$16.2M 0.02% 617